Tommaso Martino De Pas

Grading the neuroendocrine tumors of the lung: an evidence-based proposal

Guido Rindi, Catherine Klersy, Frediano Inzani et al. · Endocrine Related Cancer · 2013 · 212 citations · Full text

Medicine, Oncology, Surgery +17

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients

Antonio Marchetti, John F. Palma, Lara Felicioni et al. · Journal of Thoracic Oncology · 2015 · 184 citations · Full text

Medicine, Oncology, Pharmacology +17

Initial phase II results with crizotinib in advanced <i>ALK</i>-positive non-small cell lung cancer (NSCLC): PROFILE 1005.

Lucio Crinò, D. Kim, Gregory J. Riely et al. · Journal of Clinical Oncology · 2011 · 174 citations

Medicine, Oncology, Pharmacology +15

Results of a global phase II study with crizotinib in advanced <i>ALK</i>-positive non-small cell lung cancer (NSCLC).

Dong‐Wan Kim, Myung‐Ju Ahn, Yuankai Shi et al. · Journal of Clinical Oncology · 2012 · 159 citations

Medicine, Oncology, Pharmacology +15

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Vanesa Gregorc, Paolo Andrea Zucali, Armando Santoro et al. · Journal of Clinical Oncology · 2010 · 109 citations · Full text

Medicine, Oncology, Pharmacology +15